Elevated systemic levels of inflammatory cytokines in older women with persistent cervical human papillomavirus infection.

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Troy J KempLigia A Pinto

Abstract

Defects in lymphoproliferative responses to mitogens/antigens in women >45 years old with a persistent type-specific human papillomavirus (HPV) infection have been reported. To determine whether these defects were associated with altered cytokine profiles, plasma and peripheral blood mononuclear cell (PBMC) culture supernatants from 50 cases (oversampled for their reduced lymphoproliferative ability) and 50 uninfected controls (oversampled for their robust lymphoproliferative ability) were examined for 24 cytokines using multiplexed bead-based immunoassays and ELISA. The following plasma cytokines were significantly increased in cases relative to controls (cases versus controls; median pg/mL): interleukin (IL)-6, 393.1 versus 14.5; IL-8, 1,128.5 versus 43.9; tumor necrosis factor-alpha (TNF-alpha), 164.1 versus 9.2; macrophage inflammatory protein-1alpha (MIP-1alpha), 1,368.9 versus 25.5; granulocyte macrophage colony-stimulating factor (GM-CSF), 13.8 versus 7.3; IL-1beta, 8.3 versus 1.6 (all P < 0.0001); and IL-1alpha, 218.2 versus 169.5 (P = 0.02). We focused our analysis on the cytokines IL-6, IL-8, TNF-alpha, and MIP-1alpha due to their high fold change (>10) and highly statistically significant difference between cases and...Continue Reading

References

Nov 11, 1992·International Journal of Cancer. Journal International Du Cancer·N MuñozN Ascunce
Jun 16, 1993·Journal of the National Cancer Institute·M H SchiffmanS Wacholder
May 1, 1997·Revista Panamericana De Salud Pública = Pan American Journal of Public Health·R HerreroL A Brinton
May 4, 2000·The New England Journal of Medicine·G C BlobeH F Lodish
Feb 15, 2001·International Journal of Cancer. Journal International Du Cancer·E Lazcano-PonceM Hernández
Mar 13, 2001·Annual Review of Immunology·L G Guidotti, F V Chisari
Apr 28, 2001·Cytokine & Growth Factor Reviews·A E KoromilasG Matlashewski
Oct 24, 2001·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·A FestaS M Haffner
Aug 15, 2002·British Journal of Cancer·M MolanoUNKNOWN HPV Study Group HPV Study
Sep 13, 2002·Journal of Medical Virology·Philip E CastleRobert D Burk
Mar 20, 2004·Revista Panamericana De Salud Pública = Pan American Journal of Public Health·M Concepción BrattiRolando Herrero
Mar 23, 2004·Annual Review of Immunology·Sidney PestkaPaul B Fisher
Oct 8, 2004·The British Journal of Nutrition·Paul Trayhurn, I Stuart Wood
Sep 23, 2006·International Journal of Cancer. Journal International Du Cancer·Silvia FranceschiNubia Muñoz
Jan 7, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Sophia S WangJoan L Walker

❮ Previous
Next ❯

Citations

May 26, 2011·Archives of Gynecology and Obstetrics·Maria Inês RosaDaniela Dorneles Rosa
Jul 11, 2013·The Journal of Infectious Diseases·Su-Hsun LiuPatti E Gravitt
Jul 1, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Anil K ChaturvediAllan Hildesheim
Jul 30, 2011·Future Microbiology·Aaron A R Tobian, Ronald H Gray
Jan 27, 2016·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·P Vieira-BaptistaG Donders
Oct 4, 2012·Cytokine & Growth Factor Reviews·Jermaine I G Coward, Hagen Kulbe
Apr 12, 2016·Cytokine·Jennifer O LamGypsyamber D'Souza
Apr 16, 2016·Cytokine & Growth Factor Reviews·Ganji Purnachandra NagarajuSubasini Pattnaik
Jun 18, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Prajakta Hemant ParadkarRama Ashok Vaidya
Feb 28, 2015·Journal of Reproductive Immunology·Audrey F SaftlasLigia A Pinto
Feb 11, 2015·Oncology Letters·José Veríssimo FernandesJosélio Maria Galvão DE Araújo
May 26, 2009·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Dagistan Tolga AriozMehmet Yilmazer
Dec 11, 2007·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Ying WangSiqun Liang
Nov 25, 2017·The Laryngoscope·Carole FakhryPatti Gravitt
Mar 20, 2020·The Journal of Dermatology·Chia-Hua LinNian-Sheng Tzeng
Mar 4, 2020·Cancers·Sudipta PathakEdyta Paradowska
Jun 4, 2020·Obstetrics & Gynecology Science·Da Yong Lee, Taek Sang Lee
Nov 9, 2018·Oncology Letters·Jayra Juliana Paiva AlvesJosé Veríssimo Fernandes
May 6, 2019·International Journal of Molecular Sciences·Luca GelsominoSebastiano Andò
Oct 1, 2019·International Journal of Cancer. Journal International Du Cancer·Javid Sadri NahandMichael R Hamblin
Jun 12, 2019·International Journal of Immunogenetics·Luis Fernando L MangieriKaren B de Oliveira
Jan 13, 2015·Cancer Prevention Research·Christine M Pierce CampbellAnna R Giuliano
May 10, 2017·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Jennifer C MolokwuNavkiran Shokar
Mar 8, 2021·Gynecologic Oncology·Jieun LeeChel Hun Choi
Sep 11, 2019·Pathogens and Disease·Nima Hemmat, Hossein Bannazadeh Baghi
Jun 3, 2021·Cancers·Suellen HerbsterEnrique Boccardo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.